Principal Financial Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02M Sell
58,508
-48,204
-45% -$3.14M ﹤0.01% 1606
2026
Q1
$5.07M Buy
+106,712
New +$4.78M ﹤0.01% 1625
2025
Q3
Sell
-66,829
Closed -$2.46M 2340
2025
Q2
$2.46M Sell
66,829
-67,978
-50% -$2.35M ﹤0.01% 1771
2025
Q1
$5.29M Sell
134,807
-239,744
-64% -$10.8M ﹤0.01% 1549
2024
Q4
$17.4M Buy
374,551
+168,687
+82% +$7.62M 0.01% 943
2024
Q3
$9.3M Buy
205,864
+82,953
+67% +$3.95M 0.01% 1322
2024
Q2
$6.06M Buy
122,911
+83,287
+210% +$3.4M ﹤0.01% 1492
2024
Q1
$1.36M Buy
39,624
+23,850
+151% +$861K ﹤0.01% 1830
2023
Q4
$581K Sell
15,774
-1,689
-10% -$39.1K ﹤0.01% 1933
2023
Q3
$354K Sell
17,463
-988
-5% -$21.7K ﹤0.01% 2016
2023
Q2
$378K Buy
18,451
+485
+3% +$7.27K ﹤0.01% 2016
2023
Q1
$271K Sell
17,966
-104
-0.6% -$2.3K ﹤0.01% 2110
2022
Q4
$430K Buy
18,070
+441
+3% +$12.8K ﹤0.01% 2013
2022
Q3
$621K Buy
17,629
+4,388
+33% +$186K ﹤0.01% 1916
2022
Q2
$463K Sell
13,241
-2,535
-16% -$89.8K ﹤0.01% 2075
2022
Q1
$779K Buy
15,776
+1,881
+14% +$104K ﹤0.01% 2028
2021
Q4
$1.07M Sell
13,895
-5,835
-30% -$599K ﹤0.01% 1968
2021
Q3
$2.11M Buy
19,730
+789
+4% +$90.3K ﹤0.01% 1862
2021
Q2
$2.52M Sell
18,941
-32,108
-63% -$3.73M ﹤0.01% 1855
2021
Q1
$6.32M Buy
51,049
+5,748
+13% +$873K ﹤0.01% 1584
2020
Q4
$6.4M Buy
45,301
+33,460
+283% +$3.71M ﹤0.01% 1472
2020
Q3
$899K Sell
11,841
-114
-1% -$7.1K ﹤0.01% 1893
2020
Q2
$541K Buy
+11,955
New +$429K ﹤0.01% 1952

Other funds holding TWST

Principal Financial Group's TWST Position: Q2 2026 in Review

Principal Financial Group reduced its Twist Bioscience (TWST) stake by 45% in Q2 2026, selling an estimated $3.14M and leaving 58,508 shares worth $6.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Principal Financial Group first reported a position in TWST in Q2 2020 and has held it in 23 quarters since. The position peaked at $17.4M in Q4 2024. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Principal Financial Group held 58,508 shares of Twist Bioscience worth $6.02M as of Q2 2026.
  • Principal Financial Group sold 48,204 Twist Bioscience shares in Q2 2026, an estimated $3.14M.
  • Twist Bioscience made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1606 holding.
  • Principal Financial Group first reported a position in Twist Bioscience in Q2 2020 and has held it in 23 quarters since.
  • Principal Financial Group's Twist Bioscience position peaked at $17.4M in Q4 2024.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.